Izutsu et al., 2016 - Google Patents
Characterization and quality control of pharmaceutical cocrystalsIzutsu et al., 2016
View PDF- Document ID
- 2405227468446553990
- Author
- Izutsu K
- Koide T
- Takata N
- Ikeda Y
- Ono M
- Inoue M
- Fukami T
- Yonemochi E
- Publication year
- Publication venue
- Chemical and Pharmaceutical Bulletin
External Links
Snippet
Recent active research and new regulatory guidance on pharmaceutical cocrystals have increased the rate of their development as promising approaches to improve handling, storage stability, and bioavailability of poorly soluble active pharmaceutical ingredients …
- 238000010192 crystallographic characterization 0 title abstract description 21
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Izutsu et al. | Characterization and quality control of pharmaceutical cocrystals | |
| Cuadra et al. | Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO2 as an antisolvent | |
| Liu et al. | Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals | |
| Shayanfar et al. | Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties | |
| Alhalaweh et al. | Formation of cocrystals from stoichiometric solutions of incongruently saturating systems by spray drying | |
| Wang et al. | Anti-solvent co-crystallization of carbamazepine and saccharin | |
| Balk et al. | Ionic liquid versus prodrug strategy to address formulation challenges | |
| Pas et al. | Exploring the feasibility of the use of biopolymers as a carrier in the formulation of amorphous solid dispersions–Part I: Gelatin | |
| Garg et al. | Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs | |
| Chadha et al. | Preparation and solid-state characterization of three novel multicomponent solid forms of oxcarbazepine: Improvement in solubility through saccharin cocrystal | |
| Mohite et al. | Synthesis of fisetin co-crystals with caffeine and nicotinamide using the cooling crystallization technique: biopharmaceutical studies | |
| Wang et al. | Drug-drug cocrystals of theophylline with quercetin | |
| Sathisaran et al. | Cocrystallization of carbamazepine with amides: Cocrystal and eutectic phases with improved dissolution | |
| Salazar-Rojas et al. | Preparation and characterization of a new solid form of praziquantel, an essential anthelmintic drug. Praziquantel racemic monohydrate | |
| Gunnam et al. | Solubility improvement of curcumin with amino acids | |
| Samineni et al. | Co-crystals: a review of recent trends in co crystallization of BCS class II drugs | |
| MacEachern et al. | Transformation under pressure: Discovery of a novel crystalline form of anthelmintic drug Praziquantel using high-pressure supercritical carbon dioxide | |
| Zhan et al. | Characterization of some sucrose-based deep eutectic solvents and their effect on the solubility of piroxicam | |
| Sopyan et al. | Co-crystallization: a tool to enhance solubility and dissolution rate of simvastatin | |
| Shi et al. | Ibrutinib and carboxylic acid coamorphous system with increased solubility and dissolution: A potential interaction mechanism | |
| Tawfeek et al. | Effect of spray drying on amorphization of indomethacin nicotinamide cocrystals; optimization, characterization, and stability study | |
| Budiman et al. | Enhancement of solubility and dissolution rate of glibenclamide by cocrystal approach with solvent drop grinding method | |
| Al-Dulaimi et al. | Co-crystals for improving solubility and bioavailability of pharmaceutical products | |
| Sopyan et al. | A simple effort to enhance solubility and dissolution rate of simvastatin using co-crystallization | |
| Dutt et al. | Cocrystallization: An innovative route toward better medication |